14th May 2014 12:26
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the "Code")
1. | KEY INFORMATION |
| Bank of America Merrill Lynch | ||
| AstraZeneca PLC | ||
| Pfizer Inc | ||
| 13/05/2014 | ||
| No |
2. | DEALINGS BY THE EXEMPT PRINCIPAL TRADER |
(a) | Purchases and sales |
Class of relevant security | Purchases/sales | Total number of securities | Highest price per unit paid/received | Lowest price per unit paid/received |
Common - ISIN GB0009895292 | Purchase | 453,482 | 47.26 GBP | 46.24 GBP |
Common - ISIN GB0009895292 | Purchase | 95,163 | 522.5 SEK | 512 SEK |
Common - ISIN GB0009895292 | Sale | 382,341 | 47.27 GBP | 38.017 GBP |
Common - ISIN GB0009895292 | Sale | 96,884 | 522 SEK | 512 SEK |
(b) | Derivatives transactions (other than options) |
Class of relevant security | Product descriptione.g. CFD | Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position | Number of reference securities | Price per unit |
Common - ISIN GB0009895292 | Swaps | Long | 74 | 46.801 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 2,546 | 46.874 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 700 | 46.796 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 871 | 46.54 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 871 | 46.671 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 2,178 | 46.671 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 10,000 | 46.423 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 5,000 | 46.678 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 5,000 | 46.423 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 10,000 | 46.643 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 10,000 | 46.678 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 69 | 46.54 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 243 | 46.671 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 2,061 | 46.54 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 2,061 | 46.671 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 5,153 | 46.671 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 300 | 46.567 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 6,999 | 46.54 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 6,999 | 46.671 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 17,495 | 46.671 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 2,903 | 46.46 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 665 | 46.93 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 1,110 | 46.57 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 183 | 46.7 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 9,266 | 47.1 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 154 | 46.417 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 77,017 | 46.54 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 17,128 | 46.539 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 77,017 | 46.539 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 65,947 | 46.54 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 67,036 | 46.54 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 51,780 | 46.539 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 166 | 46.417 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 1,592 | 518.953 SEK |
Common - ISIN GB0009895292 | Swaps | Long | 429 | 515.91 SEK |
Common - ISIN GB0009895292 | Swaps | Short | 300 | 518.543 SEK |
Common - ISIN GB0009895292 | Swaps | Long | 21 | 46.801 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 29 | 46.516 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 34 | 46.801 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 5 | 46.801 GBP |
Common - ISIN GB0009895292 | Swaps | Long | 21 | 46.801 GBP |
Common - ISIN GB0009895292 | Swaps | Short | 600 | 517.922 SEK |
Common - ISIN GB0009895292 | Swaps | Long | 600 | 518.327 SEK |
(c) | Options transactions in respect of existing securities |
(i) | Writing, selling, purchasing or varying |
Class ofrelevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number ofsecurities to which option relates | Exercise priceper unit GBP | Typee.g. American, European etc. | Expiry date | Option money paid/ received per unit GBP |
Common - ISIN GB0009895292 | Call Option | Selling | 300 | 48 | American | 21/06/2014 | 1.3 |
Common - ISIN GB0009895292 | Call Option | Selling | 100 | 48 | American | 21/06/2014 | 1.3 |
Common - ISIN GB0009895292 | Call Option | Selling | 2000 | 48 | American | 21/06/2014 | 1.3 |
Common - ISIN GB0009895292 | Call Option | Purchasing | 5000 | 52 | American | 21/06/2014 | 0.4 |
Common - ISIN GB0009895292 | Call Option | Purchasing | 2500 | 52 | American | 21/06/2014 | 0.5 |
Call Option | Selling | 2000 | 48 | American | 21/06/2014 | 2.85 |
(ii) | Exercising |
Class of relevant security | Product descriptione.g. call option | Number of securities | Exercise Price per unit |
N/A | N/A | N/A | N/A |
(d) | Other dealings (including subscribing for new securities) |
Class of relevant security | Nature of dealinge.g. subscription, conversion | Details | Price per unit (if applicable) |
N/A | N/A | N/A | N/A |
The currency of all prices and other monetary amounts should be stated.Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional classof relevant security dealt in.
3. | OTHER INFORMATION |
(a) | Indemnity and other dealing arrangements |
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" |
None |
(b) | Agreements, arrangements or understandings relating to options or derivatives |
Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) The voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" |
None |
Date of disclosure: | 14/05/2014 |
Contact name: | Stacy Otieno |
Telephone number: | 0207 995 1335 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at [email protected].The Panel's Market Surveillance Unit is available for consultation in relation to the Code'sdealing disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the "Code")
1. | KEY INFORMATION | |||||
| Bank of America Merrill Lynch | |||||
| Pfizer Inc | |||||
| Pfizer Inc | |||||
| 13/05/2014 | |||||
| No | |||||
2. | DEALINGS BY THE EXEMPT PRINCIPAL TRADER |
(a) | Purchases and sales |
Class of relevant security | Purchases/sales | Total number of securities | Highest price per unit paid/received | Lowest price per unit paid/received |
Common - ISIN US7170811035 | Purchase | 364 | 191.5 SEK | 191 SEK |
Common - ISIN US7170811035 | Sale | 364 | 191.5 SEK | 191 SEK |
Common - ISIN US7170811035 | Sale | 1,503 | 29.195 USD | 29.195 USD |
(b) | Derivatives transactions (other than options) | ||||||
Class of relevant security | Product descriptione.g. CFD | Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position | Number of reference securities | Price per unit | |||
N/A | N/A | N/A | N/A | N/A | |||
(c) | Options transactions in respect of existing securities |
(i) | Writing, selling, purchasing or varying |
Class ofrelevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number ofsecurities to which option relates | Exercise priceper unit | Typee.g. American, European etc. | Expiry date | Option money paid/ received per unit |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
(ii) | Exercising | |||||
Class of relevant security | Product descriptione.g. call option | Number of securities | Exercise Price per unit | |||
N/A | N/A | N/A | N/A | |||
(d) | Other dealings (including subscribing for new securities) | |||||
Class of relevant security | Nature of dealinge.g. subscription, conversion | Details | Price per unit (if applicable) | |||
N/A | N/A | N/A | N/A | |||
The currency of all prices and other monetary amounts should be stated.Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional classof relevant security dealt in.
3. | OTHER INFORMATION |
(a) | Indemnity and other dealing arrangements |
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" |
None |
(b) | Agreements, arrangements or understandings relating to options or derivatives |
Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) The voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" |
None |
Date of disclosure: | 14/05/2014 |
Contact name: | Stacy Otieno |
Telephone number: | 0207 995 1335 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at [email protected].The Panel's Market Surveillance Unit is available for consultation in relation to the Code'sdealing disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
Related Shares:
AstrazenecaPFZ.L